本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Aura Biosciences, Inc.

6.44
-0.1500-2.28%
盤後6.440.00000.00%19:30 EDT
成交量:377.67萬
成交額:2,441.29萬
市值:6.66億
市盈率:-3.63
高:6.73
開:6.73
低:6.43
收:6.59
52周最高:9.54
52周最低:4.73
股本:1.03億
流通股本:7,991.55萬
量比:4.47
換手率:4.73%
股息:- -
股息率:- -
每股收益(TTM):-1.7726
每股收益(LYR):-1.7599
淨資產收益率:-53.49%
總資產收益率:-31.24%
市淨率:2.11
市盈率(LYR):-3.66

資料載入中...

2022/03/23

重要事件披露

8-K - Current report
2022/03/23

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/26

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/24

重要事件披露

8-K - Current report
2021/11/24

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/10

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/11/04

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/11/02

重要事件披露

8-K - Current report
2021/10/29

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/10/26

SEC問詢函

CORRESP [Cover] - Correspondence
2021/10/26

SEC問詢函

CORRESP [Cover] - Correspondence
2021/10/25

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/10/25

SEC問詢函

CORRESP [Cover] - Correspondence
2021/10/08

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933